Related Experiment Video

Updated: Sep 10, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and

G Fragasso1, R G Xuereb, M Xuereb

  • 1Divisione di Cardiologia, Istituto Scientifico H San Raffaele, Milano. fragasg@hsr.it

Cardiologia (Rome, Italy)
|May 18, 1999
PubMed

Insights

This study examined long-term changes in heart function for patients with coronary artery disease and limited coronary flow reserve who received medical treatment. It explored how these changes relate to managing ischemic events in this patient group.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Heart Function Analysis

Background:

  • Limited data exists on the long-term cardiac function in medically treated coronary artery disease (CAD) patients with severely restricted coronary flow reserve.
  • Understanding the evolution of left ventricular function is crucial for managing patients ineligible or declining revascularization.

Purpose of the Study:

  • To evaluate the long-term changes in exercise tolerance and left ventricular function.
  • To determine the relationship between these functional changes and the control of ischemic events.
  • Focusing on patients with coronary artery disease and significant exercise-induced myocardial dysfunction who did not undergo revascularization.

Main Methods:

  • Longitudinal assessment of patients with coronary artery disease and prolonged inducible myocardial dysfunction.
  • Medical management without cardiac revascularization.
  • Evaluation of effort tolerance and left ventricular function over time.

Main Results:

  • Data on the long-term evolution of left ventricular function in this specific patient cohort is scarce.
  • The study aimed to fill this knowledge gap by analyzing functional changes and their impact on ischemic events.
  • Investigated the interplay between medical treatment, myocardial dysfunction, and clinical outcomes.

Conclusions:

  • The study provides insights into the long-term prognosis of medically managed coronary artery disease patients with impaired coronary flow reserve.
  • Findings contribute to understanding the management strategies for patients unsuitable for revascularization.
  • Highlights the importance of monitoring left ventricular function and effort tolerance in relation to ischemic event control.

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...